Drug intelligence / Profile preview

aminophylline + dexmedetomidine

Development stage
Unknown
Lead developer
Memphitis
Modality
Small Molecules
Administration
Intravenous
01

Overview

Aminophylline + dexmedetomidine is a combination of two pharmaceutical agents used in perioperative and anesthetic settings. Aminophylline is a bronchodilator and central nervous system stimulant, primarily acting as a nonselective phosphodiesterase inhibitor and adenosine receptor antagonist, leading to increased intracellular cAMP, bronchodilation, cardiac stimulation, and reduced sedation. Dexmedetomidine is a highly selective α2-adrenoceptor agonist that provides sedation, analgesia, anxiolysis, and sympatholytic effects by inhibiting neuronal firing in the brain and spinal cord. This combination has been studied for its ability to counteract the sedative effects of dexmedetomidine during procedures requiring controlled hypotension (such as functional endoscopic sinus surgery), with aminophylline shown to enhance recovery profiles by reducing extubation time and postoperative sedation through antagonism of adenosine receptors mediating hypnosis[2][3][5].

02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2B (Adenosine A2B receptor)ADORA3 (Adenosine A3 receptor)ADRA2A (α2A)HDAC2 (Histone deacetylase 2)PDE3A (Phosphodiesterase 3A)

Beyond the preview

Go deeper on aminophylline + dexmedetomidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aminophylline + dexmedetomidine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call